MedTrace Logo

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

NCT00633191 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2016-09-01

No results posted yet for this study

Summary

Hypothesis: Daily gargling with specific avian antibodies against Pseudomonas aeruginosa will prevent infections with this bacteria in patients with Cystic fibrosis (CF).

Conditions

Interventions

DRUG

Anti-pseudomonas IgY gargle

Gargle (solution), \> 5FKU, every night after toothbrushing, life-long

Sponsors & Collaborators

  • Immunsystem AB

    lead OTHER

Principal Investigators

  • Annika Hollsing, MD, PhD · Uppsala Children´s University Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00633191 on ClinicalTrials.gov